GeoVax Labs, Inc. Price Today
GeoVax Labs, Inc.
GOVX
Healthcare
$13.22M
💰
Market Cap
0
💸
Price to Earnings
$-0.7
🎉
EPS
+0
🌳
ESG
Consensus Recommendations
Buy Consensus
Buy |
7 |
Strong Buy |
2 |
Hold |
1 |
Sell |
0 |
Strong Sell |
0 |
GOVX Price Forecast Target
0.5 👉 8.0 +1500%
GOVX EPS Forecast
-0.7 👉 -0.8 +9%
Financials
Profit Margin
0 %
Revenue Growth
0 %
Dividend
$ 0
Held Percent
1.2% - Insiders
6.1% - Institutions
92.7% - Public
Major Fund Holders
-
💰 Vanguard Group Inc $402,041.0
-
💰 Blackrock Inc. $227,394.0
-
💰 Geode Capital Management, LLC $95,012.0
-
💰 State Street Corporation $53,868.0
-
💰 Morgan Stanley $27,608.0
Stock Ideas
Scott Ferguson Portfolio
With a strong background as a protégé of Bill Ackman, founder of Pershing Square Capital Management, Scott Ferguson has honed his skills and expertise in the art of activist investing. He possesses the ability to identify undervalued companies with …
Ron Baron Portfolio
Ron Baron is an American billionaire investor, entrepreneur, and the founder of Baron Capital Group, a well-known investment management firm. He is recognized for his long-term, growth-oriented investment approach and has built a successful track re…
Louis Bacon Portfolio
Louis Bacon is the founder of Moore Capital Management and is one of the famous traders of the past two decades. His personal wealth is more than $1.5 Billion and had more than $15 Billion in AUM. He has an MBA degree from Columbia Business School.
Carl Icahn Portfolio
With a staggering net worth exceeding $16 billion, Icahn has made a lasting impact on the stock market as the founder and manager of Icahn Enterprises. Known as a 'corporate raider,' Icahn has gained fame for his relentless pursuit of undervalued co…📮FAQ
Some Frequently Asked Questions.
The GeoVax Labs, Inc. industry is Biotechnology
The GeoVax Labs, Inc. sector is Healthcare
The GeoVax Labs, Inc. forecasted predicted Price to Earnings PE ratio is -0.6
The GeoVax Labs, Inc. Price to Earnings PE ratio is 0
The Market Capitalization of GeoVax Labs, Inc. is $13.22M
There are total of 26050696 float shares with 6.1% held by Institutions and 1.2% held by insiders
The MGeoVax Labs, Inc. forecasted Earnings per Share EPS is $-0.8
The GeoVax Labs, Inc. Earnings per Share EPS is -0.7
The GeoVax Labs, Inc. company has $0 gross profits with 0 profit margins
The GeoVax Labs, Inc. Earnings Growth is 0% with 0% quarterly earnings growth
The GeoVax Labs, Inc. Revenue is $0 with 0 revenue growth
The price target for GeoVax Labs, Inc. stock is $8.0 for the high target and $4.0 for the low target
The consensus analyst recommendations for GeoVax Labs, Inc. is Buy, however the decision to buy or sell the stock should be entirely yours, as you are earning your own money and hence responsible on how to allocate and spend them.
The consensus analyst recommendations for GeoVax Labs, Inc. is Buy, with the following breakdown:
- Buy: 7
- Strong Buy: 2
- Hold: 1
- Sell: 0
- Strong Sell: 0
The Beta of GeoVax Labs, Inc. is 3.0
The dividend of GeoVax Labs, Inc. is $0
The dividend yield of GeoVax Labs, Inc. is 0.025799999%
The biggest institutional and mutual fund holders of GeoVax Labs, Inc. stock are
- Vanguard Group Inc
- Blackrock Inc.
- Geode Capital Management, LLC
- State Street Corporation
The GeoVax Labs, Inc. ESG Score is 0, with the following breakdown:
- E: 0
- S: 0
- G: 0